May 2, 2019 The researchers have been acknowledged by the journal for outstanding work in environmental chemistry and environmental pollution.
May 2, 2019 The interdisciplinary team won second place for their innovative solution to address the rise of homelessness and poor health outcomes in a Minnesota county.
May 2, 2019 Funds from the Bill & Melinda Gates Foundation will support two studies to improve maternal and child health technologies.
April 29, 2019 Dr. Sarah Birken is first author of an article that is currently among the three most-accessed papers in the journal Implementation Science.
April 29, 2019 The Fellowship program provides students with funding for engaged scholarship projects that are responsive to local or global community priorities and that have an academic connection.
April 29, 2019 OJ McGhee, manager of Instructional Media Services at the Gillings School, has been awarded a 2019 Diversity Award. These annual awards recognize individuals and groups who have made significant contributions toward advancing an inclusive climate at UNC.
Rural patients who receive medical care far from home less likely to go to nursing facilities near where they live
April 26, 2019 Many patients who live in rural areas travel to urban hospitals for acute care. A recent study found that many of these patients subsequently obtain post-acute care from skilled nursing facilities that are not near their homes – and the further away the hospital, the less likely patients are to return to their home community for care.
April 25, 2019 Busola Sanusi, a doctoral candidate at the Gillings School, has received the Biopharmaceutical Section Scholarship Award from the American Statistical Association.
April 25, 2019 The traditional Chinese herb Lycii Cortex, with its powerful compound kukoamine B, could be an effective nutraceutical choice for lowering blood glucose when used alone or in combination with low doses of first-line diabetes medications.
April 25, 2019 Financial toxicity — the state when financial burden is a source of harm to individual patients — is burdensome for advanced- and metastatic-cancer patients in ways that may differ from earlier-stage patients, according to new research from the Gillings School.